Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10

FDA recall notice · announced March 26, 2014 · Mckesson Packaging Services

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10

Reason for recall

Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.

Notes

Distribution: Nationwide
Lot/code information: Lot #: 91357
Quantity: 1,557 Boxes
Status: Terminated
Products in this recall event:
- Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-05 (D-1167-2014)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.